Clinical value of TVS-CEUS in diagnosis of early endometrial carcinoma
LIAO Tao1, GONG Jinling2, FU Chixue3
1. Department of Medical Imaging,Jiangxi Provincial Corps Hospital of Chinese People’s Armed Police Force, Jiangxi 330001,China; 2. Department of Ultrasound, the Second Affiliated Hospital of Army Military Medical University, Chongqing 400038,China; 3. Department of Medical Imaging, Chongqing Municipal Corps Hospital of Chinese People’s Armed Police Force, Chongqing 4000061,China
Abstract：Objective To explore the clinical value of transvaginal sonography contrast-enhanced ultrasonography (TVS-CEUS) in the diagnosis of early endometrial carcinoma.Methods A total of 96 patients with early endometrial adenocarcinoma diagnosed pathologically from March 2016 to October 2021 were selected. All of them underwent transvaginal sonography (TVS), contrast ultrasonography (TS-CEUS) and enhanced magnetic resonance imaging (CEMRI) before surgery. The pathological examination results were used as the gold standard to compare the diagnostic value of the three methods for stage Ia endometrial cancer, and to investigate the consistency of the three examination methods for stage Ia endometrial cancer and pathological results.Results All indicators of TVS-CEUS were significantly higher than those of TVS, and the difference was statistically significant (P＜0.05), while CEMRI and TVS-CEUS showed no significant difference. Kappa test showed that TVS had poor consistency with pathology (Kappa=0.137, P=0.152), and THE Kappa values of TTVS CEUS and MRI were 0.737 and 0.819 respectively, which had fair consistency with pathology (P＜0.01).Conclusions TTVS-CEUS is characterized by high clinical value in differential diagnosis of stage Ia a endometrial carcinoma, which can be used as a preoperative routine examination method.
廖涛, 龚金玲, 付赤学. 经阴道超声造影诊断早期子宫内膜癌的临床价值[J]. 武警医学, 2022, 33(9): 751-754.
LIAO Tao, GONG Jinling, FU Chixue. Clinical value of TVS-CEUS in diagnosis of early endometrial carcinoma. Med. J. Chin. Peop. Armed Poli. Forc., 2022, 33(9): 751-754.
Marret H, Sauget S, Giraudeau B, et al.Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses[J].Ultrasound Med,2004,23(2): 1629-1639.
[2]
Testa A C, Ferrandina G, Fruscella E, et al.The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study[J].Ultrasound Med, 2005, 24(9): 1267-1278.
Su Q,Sun Z,Lv G. Contrast enhanced ultrasound in diagnosis of endometrial carcinoma and endometrial hyperplasia[J].Cell Mol Biol (Noisy-le-grand),2018, 64(11):88-91.
[6]
Green R W, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performancein endometrial cancer staging[J].Ultrasound Obstet Gynecol,2020,56(1):96-105.
[7]
林仲秋.子宫内膜癌诊治指南解读[J].浙江医学, 2015, 37(22):1799-1803.
[8]
Epstein E, Van C, Mascilini F,et al. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size[J]. Ultrasound Obstet Gynecol, 2011,11(2): 586-593.
[9]
Verbakel J Y, Mascilini F, Wynants L, et al. Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (international endometrial tumor analysis)-4 cohort[J].Ultrasound Obstet Gynecol,2020, 1(1): 115-124.
Sidhu A S, Cantisani V, Dietrich C F, et al. The EFSUMB Guidelines and Recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications[J].Ultraschall Med,2018,39(2):1055-1107.
[13]
Testa A C, Ferrandina G, Fruscella E, et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study[J]. Ultrasound Med,2005,24(9):1267-1278.
[14]
Liu Y, Tian J W, Xu Y, et al. Role of transvaginal contrast-enhanced ultrasound in the early diagnosis of endometrial carcinoma[J].Chin Med J (Engl), 2012,12(5): 416-421.
[15]
Liu Y, Xu Y, Cheng W, et al. Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms[J].Oncol Lett, 2016,12: 3763-3770.
Epstein E, Fischerova D, Valentin L,et al. Ultrasound characteristics of endometrial cancer as defined by international endometrial tumor analysis (IETA) consensus nomenclature: prospective multicenter study[J].Ultrasound Obstet Gynecol,2018,51: 818-828.
[18]
Leone F G, Timmerman D, Bourne T, et al. Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group[J]. Ultrasound Obstet Gynecol,2010,35: 103-112.
[19]
Tang M X, Mulvana H, Gauthier T, et al.Quantitative contrast-enhanced ultrasound imaging: a review of sources of variability[J].Interface Focus,2011,1:520-539.
2022, Vol. 33 
